| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.19B | 16.65B | 14.72B | 13.82B | 13.63B | 14.33B |
| Gross Profit | 12.09B | 13.62B | 11.65B | 10.75B | 10.69B | 11.16B |
| EBITDA | 6.72B | 7.61B | 6.41B | 5.80B | 5.86B | 6.51B |
| Net Income | 4.37B | 4.31B | 4.19B | 3.82B | 3.81B | 4.22B |
Balance Sheet | ||||||
| Total Assets | 32.79B | 36.82B | 33.04B | 29.76B | 26.74B | 24.59B |
| Cash, Cash Equivalents and Short-Term Investments | 19.58B | 24.09B | 21.17B | 19.83B | 18.05B | 17.03B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 5.84B | 6.74B | 5.94B | 5.36B | 5.06B | 5.63B |
| Stockholders Equity | 26.95B | 30.08B | 27.10B | 24.41B | 21.68B | 18.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.80B | 4.90B | 4.58B | 2.85B | 4.46B |
| Operating Cash Flow | 0.00 | 6.09B | 5.65B | 4.86B | 2.98B | 4.65B |
| Investing Cash Flow | 0.00 | -4.33B | -2.97B | -1.84B | -714.00M | -188.00M |
| Financing Cash Flow | 0.00 | -1.45B | -1.34B | -1.24B | -1.24B | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥112.49B | 10.90 | ― | 1.02% | 23.44% | 74.38% | |
79 Outperform | ¥66.88B | 14.86 | 13.96% | 2.16% | 13.15% | 2.96% | |
77 Outperform | ¥70.48B | 14.80 | 31.71% | 1.68% | 17.64% | 47.00% | |
74 Outperform | ¥63.20B | 10.69 | ― | 2.41% | 17.21% | 35.56% | |
70 Outperform | ¥22.68B | 7.22 | ― | 4.58% | 6.58% | 35.23% | |
66 Neutral | ¥42.54B | 18.56 | ― | 1.50% | 10.69% | 6.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |